94 related articles for article (PubMed ID: 8103389)
21. NO-independent regulatory site on soluble guanylate cyclase.
Stasch JP; Becker EM; Alonso-Alija C; Apeler H; Dembowsky K; Feurer A; Gerzer R; Minuth T; Perzborn E; Pleiss U; Schröder H; Schroeder W; Stahl E; Steinke W; Straub A; Schramm M
Nature; 2001 Mar; 410(6825):212-5. PubMed ID: 11242081
[TBL] [Abstract][Full Text] [Related]
22. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
23. Contractility of late pregnant rat myometrium is refractory to activation of soluble but not particulate guanylate cyclase.
Fulep E; Vedernikov Y; Saade GR; Garfield RE
Am J Obstet Gynecol; 2001 Jul; 185(1):158-62. PubMed ID: 11483921
[TBL] [Abstract][Full Text] [Related]
24. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium.
Buhimschi IA; San Martin-Clark O; Aguan K; Thompson LP; Weiner CP
Am J Obstet Gynecol; 2000 Dec; 183(6):1512-9. PubMed ID: 11120520
[TBL] [Abstract][Full Text] [Related]
25. [Conditions of activation of guanylate cyclase from human platelets].
Chirkov IuIu; Tyshchuk IA; Severina IS
Biokhimiia; 1988 Sep; 53(9):1520-6. PubMed ID: 2904828
[TBL] [Abstract][Full Text] [Related]
26. [Thiol-dependent activation of guanylate cyclase by organic nitrates].
Schröder H; Noack E
Z Kardiol; 1986; 75 Suppl 3():20-4. PubMed ID: 2879391
[TBL] [Abstract][Full Text] [Related]
27. [Soluble guanylate cyclase from rat platelets during experimental myocardial ischemia].
Busygina OG; Koloskov IuB; Demurov EA; Severina IS
Vopr Med Khim; 1990; 36(5):24-6. PubMed ID: 1979194
[TBL] [Abstract][Full Text] [Related]
28. Guanylate cyclase: purification, properties, free radical activation, radiolabeling, and preparation of hybridoma antibodies.
Murad F; Lewicki JA; Brandwein HJ; Mittal CK; Waldman SA
Adv Cyclic Nucleotide Res; 1981; 14():229-39. PubMed ID: 6116385
[TBL] [Abstract][Full Text] [Related]
29. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
30. [Effect of N-(6-aminohexyl)-5-chloronaphthalene-1-sulfamide (W-7) and its analogs on the activity of soluble guanylate cyclase and on human platelet aggregation].
Severina IS; Shirkov IuIu; Belushkina NN; Tyshchuk IA; Kulagin SV; Khropov IuV
Biokhimiia; 1990 Sep; 55(9):1717-24. PubMed ID: 1981851
[TBL] [Abstract][Full Text] [Related]
31. [An endogenous regulator of the guanylate cyclase activity of human platelets].
Busygina OG; Severina IS
Biokhimiia; 1990 Oct; 55(10):1812-8. PubMed ID: 1981850
[TBL] [Abstract][Full Text] [Related]
32. Carnosine as a regulator of soluble guanylate cyclase.
Severina IS; Bussygina OG; Pyatakova NV
Biochemistry (Mosc); 2000 Jul; 65(7):783-8. PubMed ID: 10951096
[TBL] [Abstract][Full Text] [Related]
33. Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase.
Schindler U; Strobel H; Schönafinger K; Linz W; Löhn M; Martorana PA; Rütten H; Schindler PW; Busch AE; Sohn M; Töpfer A; Pistorius A; Jannek C; Mülsch A
Mol Pharmacol; 2006 Apr; 69(4):1260-8. PubMed ID: 16332991
[TBL] [Abstract][Full Text] [Related]
34. Contribution of the nitric oxide-guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar-Kyoto rats.
Witte K; Schnecko A; Zuther P; Lemmer B
Cardiovasc Res; 1995 Nov; 30(5):682-8. PubMed ID: 8595613
[TBL] [Abstract][Full Text] [Related]
35. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
36. Vasorelaxant activity of some oxime derivatives.
Jaros F; Straka T; Dobesová Z; Pintérová M; Chalupský K; Kunes J; Entlicher G; Zicha J
Eur J Pharmacol; 2007 Dec; 575(1-3):122-6. PubMed ID: 17706962
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of guanylate cyclase activity of the heart and thrombocytes in normal states and in experimental allergic myocarditis].
Miroshnichenko VP; Riaposova IK; Charakh'ian IA; Kriukova GV; Severina IS
Vopr Med Khim; 1988; 34(2):34-8. PubMed ID: 2899927
[TBL] [Abstract][Full Text] [Related]
38. [Doxazosin and soluble guanylate cyclase in a rat model of hypertension].
Rodríguez-Feo JA; Gómez J; Núñez A; Rico L; Fortes J; de Andrés R; Cabestrero F; Farré J; Casado S; López-Farré A
Rev Esp Cardiol; 2001 Jul; 54(7):880-6. PubMed ID: 11446964
[TBL] [Abstract][Full Text] [Related]
39. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
40. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure.
Gupta G; Azam M; Yang L; Danziger RS
J Clin Invest; 1997 Sep; 100(6):1488-92. PubMed ID: 9294115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
